Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Molecular Measurable Residual Disease Detection in Acute Myeloid Leukemia Using Error Corrected Next Generation Sequencing

Nikhil Patkar, MD, Anam Fatima Shaikh, Chinmayee Kakirde, Rakhi Salve, Prasanna Bhanshe, Gaurav Chatterjee, MD, Sweta Rajpal, Swapnali Joshi, Shruti Chaudhary, Rohan Kodgule, Dhanlaxmi Lalit Shetty, PhD, Hasmukh Jain, MD, Bhausaheb Bagal, MD DM, Hari Menon, MD, Navin Khattry, MD DM, Manju Sengar, MD DM, Prashant Tembhare, MD, Papagudi Ganesan Subramanian, MD, Sumeet Gujral, MD

Blood (2020) 136 (Supplement 1): 5–6.

https://doi.org/10.1182/blood-2020-143457

Published: 2020

Journal Articles

Immunophenotypic Assessment of Minimal Residual Disease in Younger Acute Myeloid Leukemia Patients Is Highly Predictive of Outcome

Blood (2018) 132 (Supplement 1): 1498.

https://doi.org/10.1182/blood-2018-99-116837

Published: 2018

Journal Articles

Presence of Minimal Residual Disease at End of Induction in Acute Myeloid Leukemia Is Predictive of Poor Outcome

Blood (2017) 130 (Supplement 1): 5109.

https://doi.org/10.1182/blood.V130.Suppl_1.5109.5109

Published: 2017

Journal Articles

Over-Expression of ERG Predicts Poor Outcome in Acute Myeloid Leukemia

Syed Khizer Hasan, PhD, Nikhil Patkar, MD, Devanand Vishwakarma, MSc, Deepan Rajamanickam, MD, Anant Gokarn, MD, Arvind Sahu, MD, Prashant Tembhare, MD, Sadhana Kannan, MSc, Sumeet Gujral, MD, Bhausaheb Bagal, MD DM, Hasmukh Jain, MD, Hari Menon, MD, Manju Sengar, MD DM, Pratibha Kadam Amare, PhD, Papagudi Ganesan Subramanian, MD, Navin Khattry, MD DM

Blood (2017) 130 (Supplement 1): 3920.

https://doi.org/10.1182/blood.V130.Suppl_1.3920.3920

Published: 2017

Journal Articles

Minimal Residual Disease in Acute Myeloid Leukemia Using a Difference from Normal Approach Is Predictive of Outcome

Chinmayee Kakirde, Rohan Kodgule, Goutham Raval, Sanjay Talole, Shraddha Kadechkar, Gaurav Chatterjee, Badrinath Yajamanam, Sitaram Ghoghale, Nilesh Deshpande, Pratibha Amare Kadam, PhD, Hari Menon, MD DM., Manju Sengar, Navin Khattry, MD DM, Hasmukh Jain, Bhausaheb Bagal, MD DM, Prashant Tembhare, MD, Sumeet Gujral, MD, Nikhil Patkar, MD

Blood (2016) 128 (22): 5249.

https://doi.org/10.1182/blood.V128.22.5249.5249

Published: 2016

Journal Articles

Plasmacytoid Dendritic Cell Levels at End of Induction Are Predictive of MRD Clearance and Also Influence Disease Outcome in a Subset of Patients

Papagudi Ganesan Subramanian, MD, Nikhil Patkar, MD, Prashant Tembhare, MD, Yajamanam Badrinath, Sitaram Ghoghale, Sumeet Gujral, MD, Hari Menon, MD DM, Hasmukh Jain, Bhausaheb Bagal, MD DM, Manju Sengar, Navin Khattry, MD DM

Blood (2016) 128 (22): 5263.

https://doi.org/10.1182/blood.V128.22.5263.5263

Published: 2016

Journal Articles

A Retrospective Cohort Study to Evaluate the Outcomes of HIV-Associated High-Grade B-Cell Non-Hodgkin Lymphoma (NHL) Treated with Dose Adjusted R EPOCH Regimen

Hasmukh Jain, Manju Sengar, Hari Menon, MD DM, Tanuja Shet, MD, Epari Sridhar, MD Pathology, Bhausaheb Bagal, MD DM, Siddhartha Laskar, MD Radiation Oncology, Sumeet Gujral, MD, Navin Khattry, MD DM, Archi Agarwal, Nuclear MD cine, Deepa SUSAN Philip, MD

Blood (2016) 128 (22): 4213.

https://doi.org/10.1182/blood.V128.22.4213.4213

Published: 2016

Journal Articles

Prevalence and Clinico-Pathological Attributes of c-MYC Rearranged High-Grade B-Cell Non Hodgkin Lymphomas (NHL): Single Centre Experience

Manju Sengar, MD DM, Sridhar Epari, Hasmukh Jain, MDDM, Tanuja Shet, MD, Sumeet Gujral, MD, Hari Menon, MD DM, Uma Dangi

Blood (2015) 126 (23): 5031.

https://doi.org/10.1182/blood.V126.23.5031.5031

Published: 2015

Journal Articles

Thiopurine Methyl Transferase (TPMT) Activity and Erythrocyte Thioguanine Nucleotide Levels Are Reliable Markers of Tolerability to 6-Mercaptopurine in Adult Acute Lymphoblastic Leukemia

Manju Sengar, MD DM, Murari Gurjar, Anand Patil, Vikram Gota, Hasmukh Jain, MDDM, Hari Menon, MD DM, Uma Dangi

Blood (2015) 126 (23): 3761.

https://doi.org/10.1182/blood.V126.23.3761.3761

Published: 2015

Journal Articles

Pharmacokinetic and Pharmacodynamic Properties of a Biosimilar Rituximab (Reditux ® ) Are Identical to the Innovator Brand MabThera ® – Experience from a Tertiary Cancer Centre in Western India

Hari Menon, MD DM, Akanksha Yadav, Msc, P.G Subramanian, MD, Manju Sengar, MD DM, Sanhita Rath, MS, Krunal Kavathiya, MPharm, Vikram Gota, MD

Blood (2014) 124 (21): 2246.

https://doi.org/10.1182/blood.V124.21.2246.2246

Published: 2014

Journal Articles

Correlation of FDG-PET-CT with Bone Marrow Aspiration and Biopsy at the Initial Staging in Follicular Lymphoma: Can We Omit Bone Marrow Biopsy in Some?

Manju Sengar, MD DM, Hasmukh Jain, MDMDcine, D.M MDcal Oncology, Venkatesh Rangarajan, Archi Agrawal, Hari Menon, MD DM, Sridhar Epari, Tanuja Shet, Sumeet Gujral, MD, Uma Dangi, Siddhartha Laskar, Nehal Khanna

Blood (2014) 124 (21): 4436.

https://doi.org/10.1182/blood.V124.21.4436.4436

Published: 2014

Journal Articles

Minimal Residual Disease by Multiparametric Flow Cytometry Predicts Relapse Free Survival better than Over-Expression of WT1 and BAALC in Acute Myeloid Leukemia

Syed Khizer Hasan, PhD, Nikhil V Patkar, MD DNB Clinician Scientist & Asst Professor, Devanand Vishwakarma, MS, Deepen Rajamanickam, MD, Arvind Sahu, MD, Prashant Tembhare, MD, Sadhna Kannan, PhD, Sumeet Gujral, MD, Bhausaheb Bagal, MD DM., Hari Menon, MD DM, Manju Sengar, MD DM, Pratibha Kadam Amare, PhD, PG Subramanian, MD, Navin Khattry, MDDM

Blood (2014) 124 (21): 1064.

https://doi.org/10.1182/blood.V124.21.1064.1064

Published: 2014

Journal Articles

Pretransplant PET Positivity Predicts Early Relapse with Poor Outcome in Patients of Multiple Myeloma Undergoing Autologous Stem Cell Transplantation

Bhausaheb Bagal, MD DM., Hasmukh Jain, MDMDcine, D.M MDcal Oncology, Uma Dangi, Manju Sengar, MD DM, Sadhana Kannan, Venkatesh Rangarajan, Hari Menon, MD DM., Navin Khattry, MDDM

Blood (2014) 124 (21): 3997.

https://doi.org/10.1182/blood.V124.21.3997.3997

Published: 2014

Journal Articles

Association Between CYP3A4 Polymorphisms, Trough Imatinib Plasma Concentration and Cytogenetic Response in Chronic Phase Chronic Myeloid Leukemia (CML-CP)

Vikram Gota, MD, PGDCT, Anupam Sharma, MSc, Amey Paradkar, Anand Patil, M.Pharm, Navin Khattry, MD, DM, Hari Menon, MD, DM, Anuradha Choughule, PhD, Pratibha Amare, PhD, Shripad Banavali, Brijesh Arora, MD, DM

Blood (2012) 120 (21): 3788.

https://doi.org/10.1182/blood.V120.21.3788.3788

Published: 2012

NARROW

Molecular Measurable Residual Disease Detection in Acute Myeloid Leukemia Using Error Corrected Next Generation Sequencing

Immunophenotypic Assessment of Minimal Residual Disease in Younger Acute Myeloid Leukemia Patients Is Highly Predictive of Outcome

Presence of Minimal Residual Disease at End of Induction in Acute Myeloid Leukemia Is Predictive of Poor Outcome

Over-Expression of ERG Predicts Poor Outcome in Acute Myeloid Leukemia

Minimal Residual Disease in Acute Myeloid Leukemia Using a Difference from Normal Approach Is Predictive of Outcome

Plasmacytoid Dendritic Cell Levels at End of Induction Are Predictive of MRD Clearance and Also Influence Disease Outcome in a Subset of Patients

A Retrospective Cohort Study to Evaluate the Outcomes of HIV-Associated High-Grade B-Cell Non-Hodgkin Lymphoma (NHL) Treated with Dose Adjusted R EPOCH Regimen

Prevalence and Clinico-Pathological Attributes of c-MYC Rearranged High-Grade B-Cell Non Hodgkin Lymphomas (NHL): Single Centre Experience

Thiopurine Methyl Transferase (TPMT) Activity and Erythrocyte Thioguanine Nucleotide Levels Are Reliable Markers of Tolerability to 6-Mercaptopurine in Adult Acute Lymphoblastic Leukemia

Pharmacokinetic and Pharmacodynamic Properties of a Biosimilar Rituximab (Reditux ® ) Are Identical to the Innovator Brand MabThera ® – Experience from a Tertiary Cancer Centre in Western India

Correlation of FDG-PET-CT with Bone Marrow Aspiration and Biopsy at the Initial Staging in Follicular Lymphoma: Can We Omit Bone Marrow Biopsy in Some?

Minimal Residual Disease by Multiparametric Flow Cytometry Predicts Relapse Free Survival better than Over-Expression of WT1 and BAALC in Acute Myeloid Leukemia

Pretransplant PET Positivity Predicts Early Relapse with Poor Outcome in Patients of Multiple Myeloma Undergoing Autologous Stem Cell Transplantation

Association Between CYP3A4 Polymorphisms, Trough Imatinib Plasma Concentration and Cytogenetic Response in Chronic Phase Chronic Myeloid Leukemia (CML-CP)

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only